The mission of the AIDS clinical trials group (ACTG) network is to cure HIV and reduce the burden of disease due to HIV infection and its complications, including tuberculosis and viral hepatitis.

The HPTN is open to receiving concept proposals at any time. Consideration will be given based on available resources and research needs. 

The HVTN’s mission is to fully characterize the safety, immunogenicity, and efficacy of HIV vaccine candidates with the goal of developing a safe, effective vaccine as rapidly as possible for prevention of HIV infections globally. As such, we welcome the ideas of the scientific community regarding new proposals for HIV vaccine studies that are not currently being planned or pursued. 

Proposals for new IMPAACT studies may be submitted by internal or external investigators in the form of a study concept any time.

The ACTG Mentoring HIV Investigator Mentoring Program (MHIMP) Award and the James Hakim International HIV Investigator Mentoring Program (IHIMP) Award provide mentored opportunities for conducting advanced clinical research in the virology, immunology, pharmacology, or other aspects of HIV/AIDS, hepatitis, and TB for investigators from racial backgrounds that have historically been underrepresented in biomedical research for investigators from racial backgrounds that are underrepresented in biomedical research. The James Hakim International HIV Mentoring Program Award (IHIMP) expands the MHIMP to support international investigators to participate in ACTG research and mentoring.

The Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) scholar program seeks to increase opportunities for scientists from groups under-represented in HIV research. Successful applicants will be investigators who have received their terminal degree (MD, PhD, etc.).

The HIV Prevention Trials Network (HPTN) Scholars Program seeks to provide scholar recipients with the knowledge, skills and connections to further their careers as independent investigators in the HIV prevention research field. The HIV Prevention Trials Network (HPTN) is proud to offer two scholarship programs for early-career investigators funded through a supplement from the National Institute of Allergy and Infectious Diseases (NIAID), the National Institute on Drug Abuse (NIDA), and the National Institute of Mental Health (NIMH).

The Research and Mentorship Program (RAMP) provides structured mentorship and project funding for African American/Black, Hispanic/Latinx, Native American/American Indian/Alaska Native, Native Hawaiian, Asian and Pacific Islander medical students to forge the next generation of HIV prevention researchers with opportunities for independent research, salary funding, training, and professional development activities.

The IMPAACT Early Career Investigator Mentored Research program aim is to support early career investigators in the completion of a project using data or samples generated by IMPAACT Network studies to build research skills in the field of maternal/child HIV research and advance the mission of the IMPAACT Network.